Lymphedema Study for Arm or Leg Lymphedema

Not Recruiting

Trial ID: NCT02257970


This study compares the effectiveness of a study drug versus placebo in the treatment of lymphedema.

Official Title

Placebo-controlled, Case-controlled, Open Label Therapeutic Trial for Unilateral or Bilateral Lymphedema of Arm or Leg.

Stanford Investigator(s)

Stanley G. Rockson, MD
Stanley G. Rockson, MD

Allan and Tina Neill Professor of Lymphatic Research and Medicine


Inclusion Criteria:

   - a history of lymphedema of one or more limbs (unilateral or bilateral), with a
   duration of > 6 months.

Exclusion Criteria:

   - Patients with active cancer, infection or bleeding tendency will be excluded.

   - We will also exclude patients with medical contraindications to NSAIDs, including
   history of allergies, know gastrointestinal intolerance, or other serious systemic
   illness (e.g., renal failure, hepatic dysfunction, congestive heart failure,
   neurological or psychological impairment) that would impair the patients' ability to

   - Minors (<18 years of age) *>90 years of age


drug: Placebo

drug: Ketoprofen

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Leslie Roche, RN